UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$383M |
| 2 |
DXC Technology
DXC
|
+$191M |
| 3 |
American Express
AXP
|
+$187M |
| 4 |
Johnson & Johnson
JNJ
|
+$185M |
| 5 |
TAL Education Group
TAL
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$228M |
| 2 |
Trane Technologies
TT
|
+$133M |
| 3 |
Booking.com
BKNG
|
+$131M |
| 4 |
MON
Monsanto Co
MON
|
+$113M |
| 5 |
EOG Resources
EOG
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.35% |
| 2 | Financials | 15.6% |
| 3 | Healthcare | 12.81% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Equifax
EFX
$20.3B
| $37.7M | 0.03% |
319,568
-6,466
| -2% | -$727K |
|
|
CLVS
527
DELISTED
Clovis Oncology, Inc.
CLVS
| $37.5M | 0.03% |
552,082
+178,337
| +48% | +$12.5M |
|
|
GAP
528
The Gap Inc
GAP
$7.23B
| $37.5M | 0.03% |
1,099,622
-8,876
| -0.8% | -$265K |
|
|
AGU
529
DELISTED
Agrium
AGU
| $37.4M | 0.03% |
324,296
-9,696
| -3% | -$1.05M |
|
530
Hormel Foods
HRL
$13.8B
| $37.4M | 0.03% |
1,027,630
+18,190
| +2% | +$612K |
|
|
CA
531
DELISTED
CA, Inc.
CA
| $37.4M | 0.03% |
1,122,759
+8,030
| +0.7% | +$267K |
|
532
Berkshire Hathaway Class A
BRK.A
$1.1T
| $37.2M | 0.03% |
125
+4
| +3% | +$1.14M |
|
|
TTM
533
DELISTED
Tata Motors Limited
TTM
| $37.2M | 0.03% |
1,124,800
-201,600
| -15% | -$6.51M |
|
534
Xylem
XYL
$27.3B
| $37.1M | 0.03% |
543,329
+1,945
| +0.4% | +$129K |
|
535
British American Tobacco
BTI
$131B
| $37.1M | 0.03% |
552,954
-154,320
| -22% | -$10.1M |
|
536
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $37M | 0.03% |
975,445
+48,540
| +5% | +$1.79M |
|
|
WCN
537
Waste Connections
WCN
$42.2B
| $36.9M | 0.03% |
519,494
-20,758
| -4% | -$1.45M |
|
538
Fidelity National Financial
FNF
$13.9B
| $36.7M | 0.03% |
972,762
-314,073
| -24% | -$11.5M |
|
539
ResMed
RMD
$30.6B
| $36.7M | 0.03% |
433,163
-24,947
| -5% | -$2.06M |
|
540
Travel + Leisure Co
TNL
$4.66B
| $36.7M | 0.03% |
701,205
-3,499
| -0.5% | -$173K |
|
541
Robert Half
RHI
$3.87B
| $36.6M | 0.03% |
659,808
-151,664
| -19% | -$8.07M |
|
542
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
| – | – |
0
| – | – |
|
543
Ulta Beauty
ULTA
$22B
| $36.6M | 0.03% |
163,513
-849
| -0.5% | -$180K |
|
544
VeriSign
VRSN
$26.2B
| $36.6M | 0.03% |
319,452
+28,272
| +10% | +$3.16M |
|
545
Alliant Energy
LNT
$18.3B
| $36.3M | 0.03% |
852,629
+41,877
| +5% | +$1.83M |
|
546
Neurocrine Biosciences
NBIX
$16.8B
| $36.1M | 0.03% |
465,192
-54,520
| -10% | -$3.72M |
|
|
NLSN
547
DELISTED
Nielsen Holdings plc
NLSN
| $36.1M | 0.03% |
990,499
-10,614
| -1% | -$403K |
|
|
CTRA
548
DELISTED
Coterra Energy
CTRA
| $36M | 0.03% |
1,259,904
-20,570
| -2% | -$565K |
|
549
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $36M | 0.03% |
435,781
+25,602
| +6% | +$2.11M |
|
550
FMC
FMC
$1.34B
| $35.9M | 0.03% |
437,540
+3,214
| +0.7% | +$258K |
|
Similar funds
UBS AM's Q4 2017 Portfolio in Review
As of Q4 2017, UBS AM held 2,665 positions worth $118B, up 7.5% from $110B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS AM's Q4 2017 filing shows 135 new, 1,412 increased, 606 reduced and 93 closed positions. Its largest new stake was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M. The largest sale was Celgene Corp, an estimated $228M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2017 buy was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M.
- UBS AM added most to NetEase in Q4 2017, an estimated $383M increase.
- UBS AM's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $228M.
- UBS AM fully exited CR Bard Inc. in Q4 2017, selling an estimated $67.9M.
- UBS AM's ten largest holdings make up 16% of its $118B portfolio in Q4 2017.
- UBS AM opened 135 new positions and closed 93 in Q4 2017.
- UBS AM's portfolio value rose 7.5% quarter-over-quarter to $118B.
Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.